Answer
Pazenir (paclitaxel albumin) with carboplatin is indicated for first-line treatment of adults with non-small cell lung cancer who are not candidates for potentially curative surgery and/or radiation therapy.
Sources for this answer
- Paclitaxel (Pazenir) 5 mg/ml Powder for Dispersion for InfusionTeva UK Limited · emc · SmPC §4.1 Therapeutic Indications · Version 6Document updated
Sources checked